Intervention not reported
Recurrence · children with lower urinary tract infection
It is very uncertain whether the intervention changes recurrence (very low certainty).
1 finding from 1 review
total treatment failure · patients with human Brucellosis
Doxycycline+Rifampicin probably leads to higher total treatment failure compared with doxycycline+Streptomycin (moderate certainty).
1 finding from 1 review
Minor adverse drug reactions · patients with human Brucellosis
Doxycycline+Rifampicin showed no clear difference in minor adverse drug reactions compared with doxycycline+Streptomycin (low certainty).
1 finding from 1 review
total treatment failure · patients with human Brucellosis
Doxycycline+Rifampicin showed no clear difference in total treatment failure compared with quinolones+Rifampicin (moderate certainty).
1 finding from 1 review
Minor adverse drug reactions · patients with human Brucellosis
Doxycycline+Rifampicin showed no clear difference in minor adverse drug reactions compared with quinolones+Rifampicin (low certainty).
1 finding from 1 review
total treatment failure · patients with human Brucellosis
Doxycycline+Streptomycin showed no clear difference in total treatment failure compared with doxycycline+Gentamycin (low certainty).
1 finding from 1 review
Minor adverse drug reactions · patients with human Brucellosis
It is very uncertain whether doxycycline+Streptomycin changes minor adverse drug reactions compared with doxycycline+Gentamycin (very low certainty).
1 finding from 1 review
Patient response score Scale from: 1 to 6 · chronic rhinosinusitis in adults
1 finding from 1 review
Mean change from baseline of SNOT‐20 at the end of treatment Scale from: 0 to 5 · chronic rhinosinusitis in adults
1 finding from 1 review
Mean change from baseline of SNOT‐20 at 3 months post‐treatment Scale from: 0 to 5 · chronic rhinosinusitis in adults
1 finding from 1 review
Intervention not reported
Treatment failure at 1 month or less · patients with acute otitis media
The intervention led to higher treatment failure at 1 month or less; GRADE not reported.
1 finding from 1 review
Intervention not reported
Treatment failure at 8 to 19 days · patients with acute otitis media
The intervention led to higher treatment failure at 8 to 19 days; GRADE not reported.
1 finding from 1 review
Intervention not reported
Treatment failure at 20 to 30 days · patients with acute otitis media
The intervention showed no clear difference in treatment failure at 20 to 30 days; GRADE not reported.
1 finding from 1 review
Intervention not reported
Treatment failure at 8 to 19 days · patients with acute otitis media
The intervention led to higher treatment failure at 8 to 19 days; GRADE not reported.
1 finding from 1 review
Intervention not reported
Treatment failure at 20 to 30 days · patients with acute otitis media
The intervention showed no clear difference in treatment failure at 20 to 30 days; GRADE not reported.
1 finding from 1 review
Intervention not reported
Treatment failure at 3 months or less · patients with acute otitis media
The intervention showed no clear difference in treatment failure at 3 months or less; GRADE not reported.
1 finding from 1 review
Intervention not reported
Treatment failure at 90 days · patients with acute otitis media
The intervention showed no clear difference in treatment failure at 90 days; GRADE not reported.
1 finding from 1 review
Intervention not reported
Treatment failure at 30 to 45 days · patients with acute otitis media
The intervention showed no clear difference in treatment failure at 30 to 45 days; GRADE not reported.
1 finding from 1 review
Intervention not reported
Treatment failure at 1 month or less · patients with acute otitis media
The intervention showed no clear difference in treatment failure at 1 month or less; GRADE not reported.
1 finding from 1 review
Intervention not reported
Treatment failure at 3 months or less · patients with acute otitis media
The intervention showed no clear difference in treatment failure at 3 months or less; GRADE not reported.
1 finding from 1 review